www.eurpharmacy.com

Farmacia Online de máxima seriedad, confianza y seguridad
Envíos discretos hasta su casa u oficina

Revise suprima
Site search
Obvious advantage Tell a friend and get discount! Want to give it a try?
Lista de categorías

Genérico Loxapine - Loxitane

Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Loxitane

Genérico Loxitane

Loxapine 10/25mg

El Loxitane Genérico es un medicamento antipsicótico. Se utiliza para tratar la esquizofrenia.
Más informaión »

€0.87 Comprar!
Choose Your language:
Bookmarks sociales
Testimonios de nuestros clientes

Debo excusarme - pensaba que ustedes querian engañarme. Pero la demora era causada por un error. Recibí el encargo el jueves 8 de junio, y el otro el sábado 10 de junio. ¡ Tardo casi un mes pero fue a causa de un error en los datos de envio! Muchas gracias. - Curt

Nuestra página de facturación está certificada por:

Secure shopping certificates


Special Offer!

  • FDA Rejects Loxapine for Approval - Medscape

    RTT NewsFDA Rejects Loxapine for ApprovalMedscapeMay 5, 2012 — The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) saying that the new drug application for loxapine inhalation powder (Adasuve, Alexza Pharmaceuticals, Inc) is not ready for approval in its current .

  • Common antipsychotic drugs - GazetteNET

    Common antipsychotic drugsGazetteNETBy THE DAILY HAMPSHIRE GAZETTE Abilify (aripiprazole), Clozaril (clozapine), Fanapt (iloperidone), fluphenazine (generic only), Geodon (ziprasidone), Haldol (haloperidol), Invega (paliperidone), Loxitane (loxapine), Moban (molindone), .

  • Benzinga's Microcap Movers for Friday May 4, 2012 - Benzinga

    Benzinga's Microcap Movers for Friday May 4, 2012BenzingaAlexza Pharmaceuticals announced Thursday that it had received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application for ADASUVE (loxapine) inhalation powder, 5 mg and 10 mg.

  • Biotech Industry Hotbed of Merger & Acquisition Speculation - MarketWatch (press release)

    Biotech Industry Hotbed of Merger & Acquisition SpeculationMarketWatch (press release)The company recently received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its New Drug Application for ADASUVE (loxapine) inhalation powder.

  • Alexza Reports 2012 First Quarter Financial Results and Provides Business Update - MarketWatch (press release)

    Alexza Reports 2012 First Quarter Financial Results and Provides Business UpdateMarketWatch (press release).

Agregar a favoritos
Apuntarse a lista de correo
Trusted. Rx approved.